Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Change in Cash (2016 - 2025)

Historic Change in Cash for Regen BioPharma (RGBP) over the last 13 years, with Q4 2025 value amounting to -$64977.0.

  • Regen BioPharma's Change in Cash fell 1108364.89% to -$64977.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $4443.0, marking a year-over-year increase of 10357.26%. This contributed to the annual value of $68839.0 for FY2025, which is 15721.28% up from last year.
  • Per Regen BioPharma's latest filing, its Change in Cash stood at -$64977.0 for Q4 2025, which was down 1108364.89% from $67794.0 recorded in Q3 2025.
  • Regen BioPharma's Change in Cash's 5-year high stood at $538983.0 during Q3 2021, with a 5-year trough of -$373670.0 in Q4 2021.
  • Moreover, its 5-year median value for Change in Cash was -$13364.0 (2022), whereas its average is $254.39.
  • Per our database at Business Quant, Regen BioPharma's Change in Cash skyrocketed by 30128.62% in 2023 and then tumbled by 1108364.89% in 2025.
  • Quarter analysis of 5 years shows Regen BioPharma's Change in Cash stood at -$373670.0 in 2021, then surged by 97.2% to -$10463.0 in 2022, then soared by 133.07% to $3460.0 in 2023, then tumbled by 116.79% to -$581.0 in 2024, then plummeted by 11083.65% to -$64977.0 in 2025.
  • Its Change in Cash was -$64977.0 in Q4 2025, compared to $67794.0 in Q3 2025 and $1626.0 in Q1 2025.